Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2023 | Genomic profiling at diagnosis of myeloid neoplasms

Sanam Loghavi • 7 Sep 2023
SOHO 2023
Myelodysplastic Syndromes Myeloproliferative Neoplasms

Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of genomic profiling for patients with myeloid neoplasms, recommending targeted sequencing panels and karyotyping as a minimum at diagnosis. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Sanam Loghavi

2:47
Clinical and prognostic implications of WT1 mutations in de novo and R/R AML
Sanam Loghavi • 8 Dec 2023
2:23
The significance of variant allele frequency in patients with SF3B1-mutated MDS
Sanam Loghavi • 8 Dec 2023
1:26
BRAF-mutated AML is associated with poor prognosis and myelodysplasia-related mutations
Sanam Loghavi • 8 Dec 2023
3:07
The impact of blast enumeration & co-occurring myelodysplasia-related mutations in NPM1-mutated AML
Sanam Loghavi • 8 Dec 2023

Related Videos

1:35
Addressing the increased risk of cardiovascular disease in patients with MPNs
Arjun Ghosh • 25 Apr 2024
2:22
Haplo-SCT for older patients with AML/HR-MDS: should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024
2:31
Emerging treatment options for patients with ESA-refractory MDS: luspatercept & imetelstat
Eva Hellström-Lindberg • 11 Apr 2024
1:49
The unmet needs of patients with VEXAS syndrome
Maël Heiblig • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals